Anzeige
Mehr »
Dienstag, 02.09.2025 - Börsentäglich über 12.000 News
Blockbuster-Potenzial und Übernahmefantasie: Hier entsteht das nächste Big Pharma-Ziel!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Contract Pharma

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
25.08.Valneva's Chikungunya Shot Suspended by FDA
22.08.Nusano Cuts Ribbon on Radioisotope Production Facility
22.08.Thermo Fisher Scientific Opens Manufacturing Facility in Mebane, NC
22.08.Johnson & Johnson to Invest $2B in North Carolina Manufacturing Facility
22.08.Bio-Thera, STADA Extend Biosimilars Alliance to Tocilizumab
22.08.AAHI Taps Quratis as Preferred Vaccine Manufacturer
21.08.Andelyn Biosciences & Amplo Biotech Partner on AAV Gene Therapy Manufacturing
21.08.Parexel Taps Jim Anthony as CCO and President, Parexel Biotech
21.08.Piramal, NewAmsterdam Pharma Open Dedicated OSD Form Suite
21.08.Advanz Pharma & Alvotech Gain European Approval for Mynzepli
21.08.Kite to Acquire Interius BioTherapeutics for $350M
20.08.Schreiner MediPharm & Bluesight Introduce RFID-Based Inventory Solution
20.08.Altasciences Earns EcoVadis Gold Medal
20.08.LSPedia's Track-and-Trace Solution Expands Globally with Spring Bio Partnership
20.08.Jazz Pharmaceuticals, Saniona Enter Exclusive Agreement
20.08.Nucleus RadioPharma Appoints Dr. Stephen Hahn as CEO
19.08.FDA Approves Novo Nordisk's Wegovy for MASH
19.08.BioMed X, Novo Nordisk Launch Oral Peptide Drug Delivery Collaboration
19.08.FDA Issues Complete Response Letter for PTC's Vatiquinone NDA
18.08.IQVIA, Veeva Announce Long-term Clinical & Commercial Partnerships
18.08.Upperton Pharma Solutions Awarded VaxHub Sustainable Grant
18.08.Anocca Raises $46M to Advance Clinical Trial Targeting Pancreatic Cancer
18.08.Izalontamab Brengitecan Granted Breakthrough Therapy Designation
18.08.Ifinatamab Deruxtecan Granted Breakthrough Therapy Designation
15.08.FDA Fully Approves Precigen's Papzimeos